Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China
Clinical trial NCT05199571 · COMPLETED
Trial details
- NCT number
- NCT05199571
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-22
- Primary completion
- 2025-02-13
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.